Carregant...
Epigenetic inhibitors for the precision treatment of ARID1A-mutant ovarian cancers: what are the next steps?
Guardat en:
| Publicat a: | Expert Rev Precis Med Drug Dev |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6277026/ https://ncbi.nlm.nih.gov/pubmed/30525111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23808993.2018.1503050 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|